drugset / Trial / NCT07137559

CELZ-201-DDT for the Treatment of Chronic Lower Back Pain

NCT07137559 ↗

Expanded access Available Creative Medical Technology Holdings Inc

Summary

CELZ-201-DDT is an investigational (experimental) cell therapy currently being studied for people with degenerative disc disease who have chronic lower back pain.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject CELZ-201-DDT Cell therapy — Intramuscular